Gene signatures predict doxorubicin response in K9 osteosarcoma

University of Colorado Cancer Center members at CSU Flint Animal Cancer Center present at AACR 2015, a gene expression model that predicts canine osteosarcoma response to doxorubicin, potentially allowing veterinary oncologists to better choose which drug to use with their patients. —> Read More